NeuroSearch A/S – Status announcement for the period 1

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NeuroSearch A/S – Status announcement for the period 1 January to 30 September 2014

Announcement 13 November 2014 The NeuroSearch Group (NEUR) posted an operating loss of DKK 11 million (Q1-Q3 2013: a loss of DKK 8 million). Performance was adversely affected by a provision of DKK 5 million made in relation to the judgement by the City Court of Copenhagen discussed below. A loss after tax of DKK 6 million was recorded (Q1-Q3 2013: a profit of DKK 8 million). NeuroSearch posted a profit of approximately DKK 1.6 million from discontinued operations in Q3. At 30 September 2014, cash and cash equivalents totalled DKK 83 million (30 September 2013: DKK 94 million). Update on the company's activities

  • On 8 August 2014, NeuroSearch was convicted of share price manipulation in violation of the rules of the Danish Securities Trading Act in an action brought by the Public Prosecutor for Special Economic and International Crime (SEIC) as a result of the conviction of the company's then CEO for share price manipulation. NeuroSearch was ordered to pay a fine of DKK 5 million.
  • On 18 August, NeuroSearch appealed the decision of the City Court of Copenhagen to the Eastern High Court as the Board of Directors believed there is no basis for convicting the company of share price manipulation, and that a fine, if any, of DKK 5 million would be far too harsh. The Board of Directors further considered, based on an overall assessment, that it would be in the interest of the company's shareholders that the matter be submitted to the High Court.

Against that background, it must be expected that a clarification of the company's future will have to await the outcome of the appeal. The Eastern High Court has set the hearing of the case for late September 2015. Update on the company's assets

In October 2014, NeuroSearch A/S signed an agreement with Saniona ApS for the transfer of its rights to the development candidates NS2359 and NS2330 (tesofensine). NeuroSearch has for several years worked to raise capital for the further development of these two development candidates without success, or as an alternative to enter into agreements with third parties for the further development of the projects. It has been decided to transfer the rights to NS2359 and NS2330 to Saniona. Under the agreement, Saniona assumes the costs of maintaining the partially intertwined patent rights to NS2359 and NS2330. NeuroSearch will not receive any cash or other consideration in connection with the signing of the agreement, but under the agreement with Saniona, NeuroSearch is entitled to up to 20% of any milestones and royalties that Saniona may obtain in connection with the further development of NS2359 and NS2330 as well as of any potential drugs based on NS2359 or NS2330 that may reach the market. This leaves the patent portfolio with only the two dopidines that are related to the compound Huntexil® which was sold in 2012 to and is now being developed by Teva Pharmaceuticals, namely:

  • Seridopidine for the treatment of CNS disorders (completed Phase I)
  • Ordopidine for the treatment of CNS disorders (completed Phase I)

NeuroSearch will seek to divest the two compounds "as is", as we are not in a position to handle the further clinical development of the compounds in-house.

Moreover, the company has investments in:

  • NsGene: 26.8%
  • Atonomics: 5.2% (In October 2014, Atonomics completed a new financing. NeuroSearch elected not to participate, and our ownership interest is now 5.2%)

Licence agreements:

  • Potential milestone payments from Teva Pharmaceuticals of up to DKK 55 million relating to the development of Huntexil®
  • Potential payments from Saniona in the form of milestone payments and royalties and/or repayment of the loan of EUR 340,000 (DKK 2.5 million) provided by NeuroSearch in connection with the transfer agreement entered into with Saniona in 2012, see announcement no. 20-12
  • Potential payments from Saniona in the form of milestone payments and royalties of up to 20% in respect of development candidates NS2359 and NS2330 (tesofensine), which Saniona took over in October 2014, see announcement no. 13-14

The value of the assets listed above is subject to substantial uncertainty as no established market exists for such assets. In addition, NeuroSearch calculated the value as of 31 December 2013 of its unrecognised tax losses carried forward at approximately DKK 1.8 billion, and deductible timing differences at approximately DKK 0.5 billion, or a total of DKK 2.3 billion. Under certain conditions, a potential buyer of NeuroSearch may be able to exploit the unrecognised tax assets in full or in part.  

Outlook for 2014 In 2014, NeuroSearch expects an operating loss of approximately DKK 15 million. This does not include any loss or profit arising out of a potential sale of NeuroSearch's remaining assets. Contact Allan Andersen, CEO, mobile +45 4016 3864. About NeuroSearch NeuroSearch A/S (NEUR) is listed on NASDAQ Copenhagen A/S.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarivate's 2026 Research List Carries a Trust Test

Updated Category News Views 254

Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...

Continue Reading
PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 72

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 72

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 135

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 69

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 95

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 34

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 93

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 46

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
AutoMobility LA Puts 2028 Mobility on Center Stage

Updated Category News Views 38

Los Angeles is cramming an awful lot of automotive ambition into one Thursday. AutoMobility LA opens November 19 at the Los Angeles Convention Center, one day before the LA Auto Show begins its November 20–29 public run. Yes, there will be coffee carts, awards, creators and the usual event confetti. But beneath that polished show-floor racket sits a fairly serious...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Bond Fund Faces Investigation for Misconduct

Updated Category News Views 327

Investigation of Easterly ROCMuni High Income Bond Fund Investors of the Easterly ROCMuni High Income Municipal Bond Fund are facing troubling times. Recently, the Portnoy Law Firm initiated an investigation regarding potential securities fraud associated with this investment vehicle. If you have lost money after investing in the Easterly ROCMuni High Income, it's...

Continue Reading
Japan's Economic Transformation: Unleashing Investment Potential

Updated Category News Views 271

Understanding the Shift in Japanese Equities Japanese equities are experiencing a resurgence, and this transformation is hard to ignore. The landscape of investment in Japan is shifting rapidly, and for those keeping an eye on the developments, there are compelling reasons to be optimistic. For years, conventional thought had deemed Japan as a country facing overwhelming...

Continue Reading
Pet Grooming Services Market Growth Driven by Humanization Trends

Updated Category News Views 129

Exploring the Pet Grooming Services Market Growth The pet grooming services market is witnessing a remarkable transformation, with anticipated growth projected to reach over USD 12.05 billion during the next decade. The rising phenomenon of pet ownership, coupled with the ongoing trend of humanization, is significantly influencing this expansion. The global market was...

Continue Reading
Investors Unite Against Dow Inc. in Class Action Suit

Updated Category News Views 181

Class Action Lawsuit Filed Against Dow Inc. Pomerantz LLP has announced the filing of a significant class action lawsuit against Dow Inc. (NYSE: DOW) and certain high-ranking officials within the company. This legal move signals a definitive call to action for investors who may have been adversely affected by the company’s alleged misrepresentations and omissions...

Continue Reading
Innovative Philanthropy: A New Challenge for MrBeast

Updated Category News Views 505

Revolutionizing Philanthropy: A New Challenge for MrBeast In an exciting initiative that aims to transform the landscape of modern philanthropy, the 144K Collective has reached out to the well-known YouTube personality and philanthropy leader Jimmy Donaldson, popularly known as MrBeast. This event, titled "144K Vs. The Beast," represents a novel approach to enhancing...

Continue Reading